{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:16:52Z","timestamp":1789690612366,"version":"4.0.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,21]],"date-time":"2022-09-21T00:00:00Z","timestamp":1663718400000},"content-version":"am","delay-in-days":355,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.urolonc.2021.05.034","type":"journal-article","created":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T08:24:54Z","timestamp":1624955094000},"page":"733.e17-733.e24","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["The impact of single-nucleotide polymorphisms on intravesical recurrence after bacillus Calmette\u2013Gu\u00e9rin therapy for non-muscle invasive bladder cancer in a genome-wide association study"],"prefix":"10.1016","volume":"39","author":[{"given":"Shohei","family":"Nagakawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Shiota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naohiro","family":"Fujimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiaki","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leandro","family":"Blas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigehiro","family":"Tsukahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiji","family":"Kashiwagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ario","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junichi","family":"Inokuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Uchiumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideyasu","family":"Matsuyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatoshi","family":"Eto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2021.05.034_bib0001","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.eururo.2016.05.041","article-title":"EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2016","volume":"71","author":"Babjuk","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2021.05.034_bib0002","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.eururo.2005.12.031","article-title":"Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials","volume":"49","author":"Sylvester","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2021.05.034_bib0003","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/S0022-5347(05)64043-8","article-title":"Intravesical bacillus Calmette-Guerin versus mitomycin C for superficial bladder cancer: a formal meta-analysis of comparative studies on recurrence and toxicity","volume":"169","author":"B\u00f6hle","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2021.05.034_bib0004","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.eururo.2005.11.010","article-title":"Current practice in the management of superficial bladder cancer in the Netherlands and Belgian Flanders: a survey","volume":"49","author":"Witjes","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2021.05.034_bib0005","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/cas.12075","article-title":"Bacillus Calmette-Guerin (BCG) immunotherapy for bladder cancer: current understanding and perspectives on engineered BCG vaccine","volume":"104","author":"Kawai","year":"2013","journal-title":"Cancer Sci"},{"key":"10.1016\/j.urolonc.2021.05.034_bib0006","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s40425-017-0271-0","article-title":"Society for immunotherapy of cancer consensus statement on immunotherapy for the treatment of bladder carcinoma","volume":"5","author":"Kamat","year":"2017","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.urolonc.2021.05.034_bib0007","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1016\/j.juro.2009.07.016","article-title":"Predicting nonmuscle invasive bladder cancer recurrence and progression in patients treated with bacillus Calmette-Guerin: the CUETO scoring model","volume":"182","author":"Fernandez-Gomez","year":"2009","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2021.05.034_bib0008","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ajhg.2017.06.005","article-title":"10 Years of GWAS discovery: Biology, function, and translation","volume":"101","author":"Visscher","year":"2017","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.urolonc.2021.05.034_bib0009","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1007\/s00262-020-02533-8","article-title":"Genome-wide association study of genetic variations associated with treatment failure after intravesical bacillus Calmette-Gu\u00e9rin therapy for non-muscle invasive bladder cancer","volume":"69","author":"Shiota","year":"2020","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.urolonc.2021.05.034_bib0010","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1097\/00000478-199812000-00001","article-title":"The world health organization\/international society of urological pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder consensus conference committee","volume":"22","author":"Epstein","year":"1998","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.urolonc.2021.05.034_bib0011","series-title":"TNM classification of malignant tumours","author":"Sobin","year":"2009"},{"key":"10.1016\/j.urolonc.2021.05.034_bib0012","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/jhg.2015.68","article-title":"Japonica array: improved genotype imputation by designing a population-specific SNP array with 1070 Japanese individuals","volume":"60","author":"Kawai","year":"2015","journal-title":"J Hum Genet"},{"key":"10.1016\/j.urolonc.2021.05.034_bib0013","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1086\/519795","article-title":"PLINK: a tool set for whole-genome association and population-based linkage analyses","volume":"81","author":"Purcell","year":"2007","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.urolonc.2021.05.034_bib0014","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/ng.3020","article-title":"A three-stage genome-wide association study identifies a susceptibility locus for late radiotherapy toxicity at 2q24.1","volume":"46","author":"Fachal","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.urolonc.2021.05.034_bib0015","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4","article-title":"Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors","volume":"15","author":"Harrell","year":"1996","journal-title":"Stat Med"},{"key":"10.1016\/j.urolonc.2021.05.034_bib0016","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/9859021","article-title":"Prediction of Bacillus Calmette-Guerin response in patients with bladder cancer after transurethral resection of bladder tumor by using genetic variation based on genomic studies","volume":"2016","author":"Zhang","year":"2016","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.urolonc.2021.05.034_bib0017","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.redox.2015.08.008","article-title":"Outcome after BCG treatment for urinary bladder cancer may be influenced by polymorphisms in the NOS2 and NOS3 genes","volume":"6","author":"Ryk","year":"2015","journal-title":"Redox Biol"},{"key":"10.1016\/j.urolonc.2021.05.034_bib0018","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/232609","article-title":"Predictive biomarkers of bacillus calmette-gu\u00e9rin immunotherapy response in bladder cancer: where are we now?","volume":"2012","author":"Lima","year":"2012","journal-title":"Adv Urol"},{"key":"10.1016\/j.urolonc.2021.05.034_bib0019","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1016\/S0022-5347(05)00653-1","article-title":"Polymorphisms of the human NRAMP1 gene are associated with response to bacillus Calmette-Guerin immunotherapy for superficial bladder cancer","volume":"175","author":"Decobert","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2021.05.034_bib0020","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.eururo.2010.11.031","article-title":"NRAMP1 and hGPX1 gene polymorphism and response to bacillus Calmette-Gu\u00e9rin therapy for bladder cancer","volume":"59","author":"Chiong","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2021.05.034_bib0021","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1111\/j.1464-410X.2009.08549.x","article-title":"Association of tumour necrosis factor-alpha gene (T-1031C, C-863A, and C-857T) polymorphisms with bladder cancer susceptibility and outcome after bacille Calmette-Gu\u00e9rin immunotherapy","volume":"104","author":"Ahirwar","year":"2009","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2021.05.034_bib0022","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/bju.12844","article-title":"The role of functional polymorphisms in immune response genes as biomarkers of bacille Calmette-Gu\u00e9rin (BCG) immunotherapy outcome in bladder cancer: establishment of a predictive profile in a Southern Europe population","volume":"116","author":"Lima","year":"2015","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2021.05.034_bib0023","doi-asserted-by":"crossref","first-page":"5746","DOI":"10.1200\/JCO.2005.01.598","article-title":"Polymorphisms in inflammation genes and bladder cancer: from initiation to recurrence, progression, and survival","volume":"23","author":"Leibovici","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2021.05.034_bib0024","doi-asserted-by":"crossref","first-page":"E602","DOI":"10.3390\/ijms21020602","article-title":"Mechanisms of tumor-lymphatic interactions in invasive breast and prostate carcinoma","volume":"21","author":"Oliveira-Ferrer","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.urolonc.2021.05.034_bib0025","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1038\/s41416-019-0607-2","article-title":"Prognostic relevance of the Golgi mannosidase MAN1A1 in ovarian cancer: impact of N-glycosylation on tumour cell aggregation","volume":"121","author":"Hamester","year":"2019","journal-title":"Br J Cancer"},{"key":"10.1016\/j.urolonc.2021.05.034_bib0026","doi-asserted-by":"crossref","first-page":"5648","DOI":"10.1038\/s41388-018-0366-1","article-title":"O-GlcNAcylation mediates metastasis of cholangiocarcinoma through FOXO3 and MAN1A1","volume":"37","author":"Phoomak","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.urolonc.2021.05.034_bib0027","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.canlet.2013.04.022","article-title":"Transforming acidic coiled-coil proteins (TACCs) in human cancer","volume":"336","author":"Ha","year":"2013","journal-title":"Cancer Lett"},{"key":"10.1016\/j.urolonc.2021.05.034_bib0028","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.pharep.2017.01.001","article-title":"Secreted frizzled-related protein 2-mediated cancer events: Friend or foe?","volume":"69","author":"Liu","year":"2017","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.urolonc.2021.05.034_bib0029","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/TP.0b013e3182789a24","article-title":"B-cell-related biomarkers of tolerance are up-regulated in rejection-free kidney transplant recipients","volume":"95","author":"Viklicky","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.urolonc.2021.05.034_bib0030","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s12882-015-0141-2","article-title":"Effect of induction therapy on the expression of molecular markers associated with rejection and tolerance","volume":"16","author":"Krepsova","year":"2015","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.urolonc.2021.05.034_bib0031","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1089\/vim.2015.0079","article-title":"\u03b1-Mannosidase I protein expression in peripheral blood mononuclear cells is upregulated during hepatitis B virus infection","volume":"29","author":"Jiang","year":"2016","journal-title":"Viral Immunol"},{"key":"10.1016\/j.urolonc.2021.05.034_bib0032","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/PGP.0000000000000238","article-title":"Immunohistochemistry in the diagnosis of mucinous neoplasms involving the ovary: the Added value of SATB2 and biomarker discovery through protein expression database mining","volume":"35","author":"Strickland","year":"2015","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.urolonc.2021.05.034_bib0033","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s10456-015-9468-3","article-title":"Hypoxia-induced expression of phosducin-like 3 regulates expression of VEGFR-2 and promotes angiogenesis","volume":"18","author":"Srinivasan","year":"2015","journal-title":"Angiogenesis"},{"key":"10.1016\/j.urolonc.2021.05.034_bib0034","doi-asserted-by":"crossref","first-page":"28755","DOI":"10.18632\/oncotarget.4810","article-title":"Triple-layer dissection of the lung adenocarcinoma transcriptome: regulation at the gene, transcript, and exon levels","volume":"6","author":"Hsu","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.urolonc.2021.05.034_bib0035","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1172\/JCI92513","article-title":"Ligand-activated BMP signaling inhibits cell differentiation and death to promote melanoma","volume":"128","author":"Venkatesan","year":"2018","journal-title":"J Clin Invest"},{"key":"10.1016\/j.urolonc.2021.05.034_bib0036","article-title":"Integrated analysis of mutation data from various sources identifies key genes and signaling pathways in hepatocellular carcinoma","volume":"9","author":"Zhang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.urolonc.2021.05.034_bib0037","unstructured":"https:\/\/www.gtexportal.org\/home\/ accessed in 19 May 2021."},{"key":"10.1016\/j.urolonc.2021.05.034_bib0038","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.urolonc.2017.12.020","article-title":"Role of immunotherapy in bacillus Calmette-Gu\u00e9rin-unresponsive non-muscle invasive bladder cancer","volume":"36","author":"Mukherjee","year":"2018","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2021.05.034_bib0039","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.intimp.2016.03.007","article-title":"Antitumor activity of recombinant Bacille Calmette-Gu\u00e9rin secreting interleukin-15-Ag85B fusion protein against bladder cancer","volume":"35","author":"Takeuchi","year":"2015","journal-title":"Int Immunopharmacol"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143921002544?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143921002544?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:21:14Z","timestamp":1761042074000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143921002544"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":39,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S1078143921002544"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2021.05.034","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The impact of single-nucleotide polymorphisms on intravesical recurrence after bacillus Calmette\u2013Gu\u00e9rin therapy for non-muscle invasive bladder cancer in a genome-wide association study","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2021.05.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}